1
Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
Condition(s):Emergency ContraceptionLast Updated:October 21, 2019Completed
Ella: 218 Clinical Trials, Page 1 of 22
Hide Studies Not Open or Pending
2
Ulipristal Emergency Contraception Used Before or After Ovulation
Condition(s):ContraceptionLast Updated:July 30, 2018Completed
3
Validation of Ella Platform for Serum Nfl And GFAP Measures In Multiple Sclerosis Patients
Condition(s):Multiple SclerosisLast Updated:April 29, 2022Active, not recruiting
4
Ulipristal Acetate in Symptomatic Uterine Fibroid
Condition(s):Uterine Fibroid; Heavy Menstrual BleedingLast Updated:April 13, 2020Terminated
5
Ulipristal for Endometriosis-related Pelvic Pain
Condition(s):EndometriosisLast Updated:September 29, 2016Unknown status
6
A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
Condition(s):Emergency ContraceptionLast Updated:June 13, 2019Completed
7
Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
Condition(s):Adenomyosis; Heavy Uterine Bleeding; DysmenorrheaLast Updated:February 8, 2018Withdrawn
8
Ulipristal Acetate for Use in Early Pregnancy Loss
Condition(s):Missed Abortion; Anembryonic Pregnancy; Non-Viable PregnancyLast Updated:May 6, 2022Not yet recruiting
9
Ulipristal Acetate for Cervical Preparation
Condition(s):Termination of PregnancyLast Updated:July 1, 2020Completed
10
Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
Condition(s):FibroidLast Updated:November 18, 2016Unknown status